This episode covers:

● The high-tech wizardry behind cellular reprogramming and rewiring transcriptomic structures.

● How the discovery of the Yamanaka factors (OSKM: OCT4, SOX2, KLF4, c-MYC) eliminated the need for human embryos in stem cell research.

● Mapping the massive diversity of autism by looking at mutations across nearly 1,000 risk genes.

● Dr. Gupta's exciting, brand-new data revealing the critical role of the spinal cord as a sensory gating mechanism in autism.

● How "brain in a dish" models have moved from science fiction to standardized drug-discovery platforms for precision medicine.

From her start as a histology technician in the original Department of Anatomy to navigating modern digital workflows and next-generation sequencing, Julie shares her perspective on what has changed, what has stayed the same, and what it truly takes to stay engaged in the lab marathon for over four decades.

This episode covers:

● What the "vibe" and operational setup of a university lab looked like in 1980.

● The profound shift from hands-on reagent mixing to automated core facility testing.

● Why senior technicians hold irreplaceable institutional knowledge and continuity for new graduate students.

● How staying fresh means evolving—revealing how Julie stayed excited by working across six completely different labs.

● Essential life lessons for day one in the lab, starting with a golden rule: "Keep good notes"

Using fruit flies (Drosophila) as a genetic powerhouse model, Dr. Phan’s lab discovered that isolated brains show a shocking 30% reduction in synaptic proteins across the entire brain, fundamentally altering how neurons communicate. The discussion explores how isolation impairs learning and memory, how recovery times differ by gender, and why digital meetings can never truly replace physical, in-person social connection.

This episode covers:

● How social isolation dynamically impacts neural activity and molecular signaling brain-wide.

● The discovery that isolated fruit flies retain only about 70% of vital synaptic proteins compared to their socially experienced peers.

● Why reversing the cognitive impairments of isolation is significantly more difficult in males than in females.

● The critical roles that dopamine and serotonin neurons play in regulating and potentially reversing isolation-induced behaviors.

● The sensory puzzle of why seeing and hearing someone through a screen or a divider pales in comparison to real-world, physical interaction.

From early work with tadpoles to whole-brain studies in mice, Dr. Munz discusses how key mentorships, early career funding, and a willingness to take high-impact risks have shaped his career. Now establishing his own lab at the University of Alberta with local support from the Stollery Children's Hospital Foundation through the Women's and Children's Health Research Institute (WCHRI), he is pushing the boundaries of neuroscience.

This episode covers:

● The story behind his 2014 Science paper investigating how neuronal activity impacts circuit development in Xenopus laevis tadpoles.

● His decision to move to Switzerland for a postdoc in Dr. Boton-Roska’s lab, expanding from retina research into embryonic neocortex development.

● The critical role of early career funding, specifically the Simons Foundation Bridge to Independence Fellowship.

● Transitioning from an experimental postdoc to a professor building a team and working with lab manager Araya at the University of Alberta.

● Navigating a high-risk, high-reward phase of launching ambitious research projects aimed at high-impact publications.

As AI tools generate "hallucinations" and fake research papers, the challenge for scientists is no longer just finding data, but verifying if it is real. This episode introduces the CARE framework—a vital tool for evaluating AI-generated content—and discusses the ethics of AI in academic publishing. 

This episode covers:

● The evolution of libraries from analog sanctuaries to digital hubs. 

● How AI is changing the way researchers search for and filter data. 

● The danger of AI hallucinations and "noise" in scientific literature. 

● A breakdown of the CARE framework: Check the source, Analyze the info, Review for bias, and Evaluate accuracy. 

● Why AI cannot be a co-author and the importance of human accountability in research.

Dr. Hughes explains why this tiny insect is a foundational tool for human oncology, sharing roughly 75% of human cancer genes. The conversation dives deep into the SNR1 gene (known as SMARKC1 in humans), a critical regulator of chromatin remodeling. When this regulation fails, neural stem cells become "confused," leading to aggressive pediatric brain tumors like Atypical Rhabdoid Tumors (ATRT).

This episode covers:

● Why fruit flies are powerful models for human organ systems.

● The role of SNR1/SMARCB1 in stopping proliferation and guiding cell differentiation.

● How "stem-cell-like" cells in the wrong place lead to tumor overgrowth.

● The future of RNA-based therapies to regulate protein production.

● The importance of lab culture and mentorship in driving scientific discovery.

In this episode of Science at the Fifty-Third Degree, host Dr. Nayiar Shahid talks with Harry Wilton-Clark, a researcher at the University of Alberta's Women and Children's Health Research Institute, about a quiet revolution happening at the edges of medicine — the rise of N-of-1 therapies. These are treatments designed not for thousands of patients, but for one.

Harry's work focuses on Duchenne muscular dystrophy, a rare and fatal disease that strikes children. Using a technique called exon skipping therapy, his lab designs what he calls "genetic band-aids" — molecules that bind to a specific mutation in a patient's DNA and hide it from the body, allowing it to function more normally. The therapy isn't built for a population. It's built for a child.

This episode covers:

What Duchenne muscular dystrophy is and why it's so difficult to treat

How exon skipping therapy works — and what a "genetic band-aid" actually does

Why traditional clinical trials fail rare disease patients — and what N-of-1 trials offer instead

How patient families and advocacy organizations are driving research breakthroughs

What it felt like when a mouse that wouldn't run — finally ran

Why a single patient's treatment could become a master key for thousands of others
Harry recently represented Canada at the Falling Walls Lab in Berlin — one of 100 researchers selected from around the world to present work breaking the boundaries of science's biggest problems. The wall he chose to break: the one standing between a child and a cure.

After a decade-long journey spanning pharmaceutical quality control, drug discovery in London, diabetes research in Malaysia, and a PhD in pharmacology at the University of Alberta, Dr. Shahid is moving from the lab bench to the bridge. This series shifts the focus from dry data to the human stories, precision, and invisible systems that make scientific success possible.

In this pilot episode of Science at the Fifty-Third Degree, host Dr. Nayiar Shahid sits down with Dr. Zam Kassiri, a professor at the University of Alberta, to explore the fascinating and surprisingly delicate science of cardiac repair. After a heart attack, the heart doesn't just sit still — it begins a complex process of remodeling itself, reshaping its own structure to survive. But that same repair process, if it goes too far or lasts too long, can quietly become the source of long-term damage.